<DOC>
	<DOCNO>NCT01085357</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy CyPass Implant lower intraocular pressure ( IOP ) patient glaucoma undergo cataract surgery .</brief_summary>
	<brief_title>Study Implantable Device Lowering Intraocular Pressure Glaucoma Patients Undergoing Cataract Surgery</brief_title>
	<detailed_description>This study modify expand protocol base acceptable safety result earlier feasibility study . The trial conduct use 3:1 randomization ( treatment control ) patient screen eligibility , randomized time surgery follow 24 month postoperatively .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>Preoperative Diagnosis primary open angle glaucoma ( POAG ) Mean diurnal unmedicated IOP 21 33 mmHg Normal anterior chamber angle anatomy site implantation Operable agerelated cataract Use 3 ocular hypotensive medication ( combination medication count 2 medication ) Significant risk associate washout ocular hypotensive medication Previous glaucoma surgery ( exception laser treatment trabecular meshwork ) Previous corneal surgery Clinically significant ocular pathology , cataract glaucoma Diagnosis acute angle closure , traumatic , congenital , malignant , uveitic , pseudoexfoliative , pigmentary neovascular glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Glaucoma device</keyword>
	<keyword>Glaucoma surgery</keyword>
	<keyword>Intraocular pressure</keyword>
</DOC>